CNTX - CIK 0001842952
Context Therapeutics Inc. (CNTX) reported net income of -$36.12M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$36.12M | -35.2% |
| FY 2024 | -$26.73M | -11.5% |
| FY 2023 | -$23.96M | -61.5% |
| FY 2022 | -$14.84M | -41.9% |
| FY 2021 | -$10.46M | -257.4% |
| FY 2020 | $6.64M | - |
Context Therapeutics Inc. (CNTX) reported net income of -$36.12M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Context Therapeutics Inc.'s net income declined from $6.64M to -$36.12M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.